Advanced Cell Diagnosticsacdis A Biotechnology Company Based In Silicon Valleyspecializing In Molecular Pathology And Genomic Analysisfounded In 2006Acd Operates As A Subsidiary Of Bio Techne Corporation Since Its Acquisition In 2016The Company Focuses On Developing Innovative Tools For Rna Biomarker Detection And Analysiswhich Are Applicable In Researchdiagnosticsand Therapeutic Development Acd S Proprietary Rnascopeatechnology Is A Leading Rna In Situ Hybridization Platform That Allows For The Detection And Quantification Of Rna Biomarkers At Single Molecule Sensitivity While Maintaining Tissue Morphologythis Technology Is Utilized In Various Assays For Research And Diagnostic Purposesparticularly In Fields Such As Cancerneuroscienceand Infectious Diseasesacd Collaborates With Pharmaceutical Companies For Biomarker Validation And Develops Clinical Grade Tests Aimed At Personalized Medicineespecially In Oncologythe Company Serves Academic Researcherspharmaceutical Companiesand Clinical Laboratoriesemphasizing Precision Medicine And Global Expansion
